New Delhi, Dec 10 (SocialNews.XYZ) The Confederation of All India Traders on Friday wrote to the Securities and Exchange Board of India urging the marking regulator not to allow e-pharmacy firm PharmEasy's initial public offering.
"The business model of 'PharmEasy' which is controlled by 'API Holdings' is entirely based on gross illegality," the traders' body said in a statement.
Citing a Delhi High Court order passed in 2018, the traders' body said that sale of medicines over the internet is not allowed.
API Holdings, the parent company of the e-pharmacy firm PharmEasy has reportedly filed the 'Draft Red Herring Prospectus' to the market regulator recently.
"We believe that investor wealth worth billions is at stake if this IPO is approved by SEBI. We are sure that it will receive your kind and immediate attention," the statement added.
In addition, the traders' body alleged that the Pharmeasy has mentioned Thyrocare as its subsidiary in the DRHP submitted to the SEBI, without any order from the Competition Commission of India, whcih prevents activities that potentially may have an adverse effect on business.
The South Chemists and Distributors Association had also submitted a letter to the SEBI with requests on the same line.
Source: IANS
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz
This website uses cookies.
